ClinicalTrials.govclosed
Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells
ClinicalTrials.gov study NCT05410847. IPD Sharing: NO. Countries: 0. Publications: 1.
ShareScore
28/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 12
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 8